Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report

Authors

  • Karim Souaid
  • Bénédicte Oulès
  • Pierre Sohier
  • Lydia Deschamps
  • Sélim Aractingi Department of Dermatology, Hôpital Cochin, AP-HP, AP-HP Centre-Université de Paris, 89 rue d’Assas, FR-75006 Paris, France https://orcid.org/0000-0002-7766-2673
  • Nicolas Dupin

DOI:

https://doi.org/10.2340/00015555-3888

Keywords:

chilblains, COVID-19, SARS-CoV-2 spike protein, COVID-19 mRNA vaccine, IFN

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Matar S, Oulès B, Sohier P, Chosidow O, Beylot-Barry M, Dupin N, et al. Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature. J Eur Acad Dermatology Venereol 2020; 34: e686-e689.

https://doi.org/10.1111/jdv.16775 DOI: https://doi.org/10.1111/jdv.16775

Le Cleach L, Dousset L, Assier H, Fourati S, Barbarot S, Boulard C, et al. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing*. Br J Dermatol 2020; 183: 866-874.

https://doi.org/10.1111/bjd.19377 DOI: https://doi.org/10.1111/bjd.19377

Aschoff R, Zimmermann N, Beissert S, Günther C. Type I interferon signature in chilblain-like lesions associated with the COVID-19 pandemic. Dermatopathology 2020; 7: 57-63.

https://doi.org/10.3390/dermatopathology7030010 DOI: https://doi.org/10.3390/dermatopathology7030010

Hubiche T, Cardot-Leccia N, Le Duff F, Seitz-Polski B, Giordana P, Chiaverini C, et al. Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic. JAMA Dermatol 2021; 157: 202-206.

https://doi.org/10.1001/jamadermatol.2020.4324 DOI: https://doi.org/10.1001/jamadermatol.2020.4324

Sohier P, Matar S, Meritet J-F, Laurent-Roussel S, Dupin N, Aractingi S. Histopathologic features of chilblainlike lesions developing in the setting of the coronavirus disease 2019 (COVID-19) pandemic. Arch Pathol Lab Med 2021; 145: 137-144.

https://doi.org/10.5858/arpa.2020-0613-SA DOI: https://doi.org/10.5858/arpa.2020-0613-SA

McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol 2021; 85: 46-55.

https://doi.org/10.1016/j.jaad.2021.03.092 DOI: https://doi.org/10.1016/j.jaad.2021.03.092

Downloads

Published

2021-11-10

How to Cite

Souaid, K., Oulès, B., Sohier, P., Deschamps, L., Aractingi, S., & Dupin, N. (2021). Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report. Acta Dermato-Venereologica, 101(11), adv00589. https://doi.org/10.2340/00015555-3888

Issue

Vol. 101 No. 11 (2021): November

Section

Short Communication

Categories

License

Copyright (c) 2021 Karim Souaid, Bénédicte Oulès, Pierre Sohier, Lydia Deschamps, Sélim Aractingi, Nicolas Dupin

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC